May 10, 2017 11:02 am UTC| Business
CAMBRIDGE, Mass., May 10, 2017 -- Vericel Corporation (NASDAQ:VCEL), a leading developer of autologous expanded cell therapies for the treatment of patients with serious diseases and conditions, today announced that the...
May 10, 2017 11:02 am UTC| Business
CAMBRIDGE, Mass., May 10, 2017 -- Vericel Corporation (NASDAQ:VCEL), a leading developer of autologous expanded cell therapies for the treatment of patients with serious diseases and conditions, today announced that the...
May 10, 2017 11:02 am UTC| Business
-- Strong Dose-Dependent Transduction in All Animals Tested Regardless of the Level of Anti-AAV5 Antibodies at Pre-Administration-- -- Data Suggests AAV5 Gene Therapies May be Viable Treatments for Nearly All Patients...
May 10, 2017 11:02 am UTC| Business
-- Strong Dose-Dependent Transduction in All Animals Tested Regardless of the Level of Anti-AAV5 Antibodies at Pre-Administration-- -- Data Suggests AAV5 Gene Therapies May be Viable Treatments for Nearly All Patients...
May 10, 2017 11:02 am UTC| Business
-- Strong Dose-Dependent Transduction in All Animals Tested Regardless of the Level of Anti-AAV5 Antibodies at Pre-Administration-- -- Data Suggests AAV5 Gene Therapies May be Viable Treatments for Nearly All Patients...
Pinnacle Entertainment Reports 2017 First Quarter Financial Results
May 10, 2017 11:02 am UTC| Business
LAS VEGAS, May 10, 2017 -- Pinnacle Entertainment, Inc. (NASDAQ:PNK) ("Pinnacle" or the "Company") today reported financial results for the first quarter ended March31, 2017. Anthony Sanfilippo, Chief Executive...
Pinnacle Entertainment Reports 2017 First Quarter Financial Results
May 10, 2017 11:02 am UTC| Business
LAS VEGAS, May 10, 2017 -- Pinnacle Entertainment, Inc. (NASDAQ:PNK) ("Pinnacle" or the "Company") today reported financial results for the first quarter ended March31, 2017. Anthony Sanfilippo, Chief Executive...